Skip to main content

This job has expired

You will need to login before you can apply for a job.

Investigator I (Virology)

Employer
CSL Behring
Location
Cambridge, Massachusetts
Start date
Mar 21, 2021

View more

Discipline
Science/R&D, Virology
Required Education
Other
Position Type
Full time

Job Details

About CSL

With operations in 35+ nations and ~27,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune deficiencies, and vaccines to prevent influenza. Our therapies are also used in cardiac surgery, organ transplantation and burn treatment.

CSL is the parent company of CSL Behring and Seqirus. CSL Behring is a global leader in the protein biotherapeutics industry, focused on bringing to market biotherapies used to treat serious and often rare conditions. CSL Behring operates CSL Plasma, one of the world's largest collectors of human plasma, which is used to create CSL's therapies. Seqirus is one of the largest influenza vaccine companies in the world and is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.

We invite you to take a look at the many career possibilities available around the globe and consider building your promising future at CSL by becoming a member of our team!

Job Description

Job Summary:

This position is responsible for influenza virus generation and characterization and non-viral vector development to support influenza vaccine discovery and development.

Major Responsibilities:

Influenza virus generation and characterization through synthetic technology to improve influenza vaccine production
  • Production and characterization of influenza viruses in BL2 and BL3 laboratories.
  • Development of synthetic technology for virus generation to improve vaccine production.
  • Characterization and improvement of virus-production cell line to improve vaccine production.


Non-viral vector development for novel vaccine development
  • Development and improvement of vector to improve vaccine expression


Documentation and presentation of scientific results.
  • Write experimental protocols and prepare internal reports. Maintain lab notebooks.
  • Interact with cross-functional project teams and stakeholders, present research results and contribute to technical advancements and publications.


Lab management.
  • Maintain functional laboratory equipment and follow HSE regulation.

Minimum Qualifications:
  • PhD in Virology or related biological sciences.
  • PhD with 1-5 years' postdoc academic or pharmaceutical/biotech experience in virology. Experience with influenza or other respiratory viruses preferred.
  • Strong experience with virology especially influenza or other respiratory viruses is strongly preferred
  • Strong experience with molecular biology and/or bioinformatics is required.
  • Creative and the ability to generate accurate and reproducible results along with multi-tasking and working effectively in a fast-paced environment are critical.
  • Strong organizational, written and oral communication skills and ability to work in teams is essential.

Company

As the third largest global biotechnology company with employees in more than 35 countries, CSL Behring is focused on serving patients with serious and rare diseases, including coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease and neurological disorders. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge and support future medical research. 


CSL Behring's dynamic environment fosters innovation and attracts the best and brightest who share a commitment to helping save lives. People here are free to live their Promising FUTURES where they can fulfill their individual career aspirations and realize their potential. 


CSL Behring is committed to diversity and inclusion, both of which underpin our Values of patient focus, innovation, collaboration, integrity and superior performance. We believe that by harnessing and honoring the unique capabilities, experiences and perspectives of our people, we are better able to serve our patients.


CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited, headquartered in Melbourne, Australia, employs more than 27,000 people, and provides its life-saving medicines in more than 70 countries. 
For more information visit www.cslbehring.com. Help us deliver on our promise to save lives and protect the health of people around the world. Promising FUTURES start at CSL Behring!

Stock Symbol: CSL

Stock Exchange: Australian Securities Exchange

Company info
Phone
610-878-4000
Location
1020 First Avenue
King of Prussia
Pennsylvania
19406
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert